β-CGRP (human) is a potent vasodilator and exhibits both pro-inflammatory and anti-inflammatory activities. It acts through the calcitonin receptor-like receptor (CRLR) in complex with receptor activity-modifying proteins (RAMPs), specifically showing high potency at the CRLR/RAMP1 receptor (IC50 = 1 nM) and lower potency at the CRLR/RAMP2 receptor (IC50 = 300 nM) in cellular assays.